Repligen to Report Second Quarter 2021 Financial Results
13 juil. 2021 07h30 HE
|
Repligen Corporation
WALTHAM, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its second quarter 2021 financial results on Tuesday, July 27, 2021....
Repligen Corporation Announces Agreement to Acquire Polymem S.A.
22 juin 2021 06h30 HE
|
Repligen Corporation
WALTHAM, Mass., June 22, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into...
Repligen Corporation to Present at Upcoming Investor Conferences
25 mai 2021 07h30 HE
|
Repligen Corporation
WALTHAM, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present...
Repligen Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance
04 mai 2021 07h30 HE
|
Repligen Corporation
Reported revenue was $142.8 million for the quarter, representing year-over-year growth of 88% and organic growth of 69%Growth driven by combination of COVID-related demand, base business strength and...
Repligen to Report First Quarter 2021 Financial Results
20 avr. 2021 07h30 HE
|
Repligen Corporation
WALTHAM, Mass., April 20, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2021 financial results on Tuesday, May 4, 2021....
Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
17 mars 2021 07h30 HE
|
Repligen Corporation
WALTHAM, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present...
Repligen Corporation to Present at Barclays Global Healthcare Conference
03 mars 2021 07h30 HE
|
Repligen Corporation
WALTHAM, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present...
Repligen Reports Fourth Quarter and Full Year 2020 Financial Results
24 févr. 2021 07h30 HE
|
Repligen Corporation
Reports quarterly revenue of $108.6 million, representing 56% year-over-year growth, and annual revenue of $366.3 million represents 36% year-over-year growthOrganic revenue growth was 47% for the...
Repligen Corporation to Present at 10th Annual SVB Leerink Healthcare Conference
22 févr. 2021 07h30 HE
|
Repligen Corporation
WALTHAM, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present...
Repligen to Report Fourth Quarter and Full Year 2020 Financial Results
11 févr. 2021 15h00 HE
|
Repligen Corporation
Webcast and Conference Call to Be Held Wednesday, February 24, 2021 at 8:30 a.m. ESTWALTHAM, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the...